4.8 Article

An SCN9A channelopathy causes congenital inability to experience pain

Journal

NATURE
Volume 444, Issue 7121, Pages 894-898

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nature05413

Keywords

-

Funding

  1. Medical Research Council [G9717869] Funding Source: researchfish
  2. Medical Research Council [G9717869] Funding Source: Medline
  3. Wellcome Trust [057964, 071187] Funding Source: Medline
  4. MRC [G9717869] Funding Source: UKRI

Ask authors/readers for more resources

The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype. In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3. This region contains the gene SCN9A, encoding the alpha-subunit of the voltage-gated sodium channel, Na(v)1.7, which is strongly expressed in nociceptive neurons. Sequence analysis of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X). We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Na(v)1.7 with sodium channel beta(1) and beta(2) subunits in HEK293 cells. In cells expressing mutant Nav1.7, the currents were no greater than background. Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans. These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available